ARCHIVES

Congress Approves More Favorable Terms for Office-Administered Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 31 | August 8, 1997

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

Patients Who Smoke In Treatment Do Worse Than Those Who Quit

March 25, 2011

Sexual Function Affected By Stem Cell Transplant

September 28, 2007